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ABSTRACT
Reconstructing full-length transcript isoforms from
sequence fragments (such as ESTs) is a major
interest and challenge for bioinformatic analysis of
pre-mRNA alternative splicing. This problem has
been formulated as finding traversals across the
splice graph, which is a directed acyclic graph (DAG)
representation of gene structure and alternative
splicing. In this manuscript we introduce a probab-
ilistic formulation of the isoform reconstruction
problem, and provide an expectation-maximization
(EM) algorithm for its maximum likelihood solution.
Using a series of simulated data and expressed
sequences from real human genes, we demonstrate
that our EM algorithm can correctly handle various
situations of fragmentation and coupling in the
input data. Our work establishes a general probab-
ilistic framework for splice graph-based reconstruc-
tions of full-length isoforms.
INTRODUCTION
Alternative splicing is a widespread mechanism of gene regu-
lation in higher eukaryotes (1–3). It refers to the production
of different mRNA transcripts from a single gene through
alternative combinations of exons or alternative selections
of splice sites (4). Among multi-exon genes in the human
genome, it is estimated that as many as 74% are alternatively
spliced (2). Alternative splicing can impact important func-
tional regions of the proteins, such as protein interaction
domains (5) and structural elements (6,7), leading to multiple
protein products with distinct functions. It can be regulated in
a tissue-specific (8) or developmental-dependent (9) manner.
Aberrant alternative splicing is a major cause for many
human diseases (10).
There are two types of experimental data for detecting
alternative splicing: full-length sequences and sequence
fragments. Sequencing of cDNAs can reveal the complete
set of splicing events of full-length transcripts, leading to
discoveries of splice variants (11). By contrast, most high-
throughput genomic technologies [such as shotgun sequen-
cing of ESTs (12) and oligonucleotide microarrays (13)]
produce information about sequence fragments. The vast
majority of alternative splicing events in the human and
other eukaryotic genomes are discovered using fragmentary
sequence data, such as ESTs (1) and microarray probe signals
(2). ESTs are short fragments of full-length mRNA sequences
(12). To date over 6.5 million human ESTs have been depos-
ited in the UniGene database (compared to 200 000 full-
length mRNAs, see the statistics at http://www.ncbi.nlm.
nih.gov/UniGene/UGOrg.cgi?TAXID¼9606), which are
extremely useful for discovering mRNA diversity, such as
alternative splicing. However, as sequence fragments, ESTs
only provide partial information on the complete gene struc-
ture (e.g. how 2 exons are combined). It is difficult to infer
the likely functional impact of a splice variant, without the
knowledge of its full-length transcript and protein product
(14). In fact, over 80% of alternative splicing events in
the human transcriptome are detected from EST sequences,
with no corresponding full-length transcript or protein
sequences available in sequence databases, such as GenBank
(15). This problem becomes even more complicated in
splicing microarrays, which return highly fragmentary
information from probes targeting specific exons or exon–
exon junctions (2,16,17). For these reasons, the computa-
tional reconstruction of full-length transcript isoforms
from sequence fragments becomes an important problem
and challenge for bioinformatic analyses of alternative
splicing (18).
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Over the years, there has been a large body of work on this
isoform reconstruction problem (15,19–28). The centerpiece
of these studies is a graph representation of gene structure
and alternative splicing, often referred to as the ‘splice
graph’. In a pioneering study, Heber and colleagues intro-
duced the concept of splice graph (23), which represented
exons as nodes and splicing events as directed edges (see
Figure 1 for a simple illustration). Different types of alternat-
ive splicing events, such as exon skipping, alternative donor/
acceptor splice sites, mutually exclusive exon usage, intron
retention, can be easily represented using splice graphs (e.g.
see the representation of exon skipping events in Figure 1).
The problem of isoform reconstruction can be formulated
as a splice graph traversal problem (15,23,29). Due to altern-
ative splicing, multiple traversals exist, corresponding to mul-
tiple isoforms of the gene (see Figure 1). Some methods
enumerate all possible traversals across the splice graph
(23,24). For genes with multiple alternatively spliced regions,
such methods potentially generate a large number of random
exon combinations. Several other methods use certain rules to
produce a minimal set of traversals sufficient to explain all
the input data (15,20–22). In some cases the results of iso-
form reconstruction are dependent on the order of sequence
observations in the input data (15,18).
Despite the vital contributions by these studies, several
aspects of isoform reconstruction need to be improved.
First, many genes have multiple alternatively spliced regions
and complex patterns of alternative splicing (30,31). Multiple
alternative splicing events in a single gene can be regulated in
a highly coordinated fashion as shown experimentally in
fibronectin, and other genes (32). One classic example is
the alternative splicing of CD44. Only 20 isoforms have
been observed for CD44, despite the possibility of 1000
random combinations of cassette exons (33,34). It is estim-
ated that coupling of alternative splicing exists in at least
25% of alternatively spliced genes (32). In principle a splice
graph traversal algorithm based on dynamic programming
[such as the Heaviest Bundling algorithm of ours (15)],
which makes local choices for finding the optimal traversal,
cannot guarantee the correct treatment of coupled edges in
the splice graph. Second, not all traversals across the splice
graph are equally likely. It is important for the isoform recon-
struction algorithm to reflect the strength of evidence for a
particular splice graph traversal. An essential question is
how to weigh evidence from sequence fragments, which
might be consistent with a large number of traversals of the
splice graph. These issues point to the need for an explicitly
probabilistic approach to the isoform reconstruction problem.
In this manuscript, we introduce a probabilistic formulation
of the isoform reconstruction problem, and provide a solution
based on the maximum likelihood principle. EM algorithm
(35) has been used in many areas of computational biology,
such as haplotype inference (36), evolutionary selection
pressure (e.g. Ka/Ks) estimation (37), predictions of domain–
domain interactions (38) and motif detection (39), etc. We
describe an EM algorithm to estimate the probability for
each traversal across the splice graph, which maximizes the
total likelihood of the observed input data. A large body of
work has used expressed sequences to reconstruct full-length
isoforms (15,19–28), or to quantify alternative splicing on the
exon level (8,40–42). Consistent with these previous studies,
here we use a series of simulated sequence observations and
expressed sequences of real human genes to demonstrate our
probabilistic reconstruction of full-length isoforms from
splice graphs. We want to emphasize that our method is not
limited to the analyses of EST data. A variety of high-
throughput genomic technologies [such as mass spectrometry
(43), microarray (2), massively parallel signature sequencing
(MPSS) (44), etc] produce fragments that can be used to
detect alternative splicing. The goal of this manuscript is to
establish a general probabilistic framework for splice graph-
based reconstruction of full-length isoforms.
MATERIALS AND METHODS
Enumeration of putative isoforms from the splice graph
A splice graph is a directed acyclic graph (DAG), whose
nodes represent exons and edges represent splicing events
(23) (see Figure 1). We enumerated all possible traversals
across the splice graph using a breadth-first-search (BFS)
algorithm. These traversals corresponded to putative isoforms
of a gene. We compared each sequence observation with each
putative isoform to derive their consistency relationship. A
sequence observation was defined as being consistent with
a putative isoform if it was fully contained in the putative iso-
form. We constructed an indicator matrix, which recorded the
consistency relationship of all sequence observations with all
putative isoforms (see details below).
Probabilistic formulation and EM algorithm
Multinomial model with uncommitted categorization. Sup-
pose there are K possible isoforms for a gene. Let’s denote
them by I1, I2, . . . , IK. For each sequence observation, the
probability that it is generated by isoform Ik is pk, where
k ¼ 1, . . . , K and p1 + p2 + . . . + pK ¼ 1. This probability
model is called multinomial model.
Suppose we observe N sequence observations. Let’s denote
them by O1, O2, . . . , ON. We can use an N · K indicator
matrix Z ¼ (zi,k)i¼1, . . . , N, k¼1, . . . , K to record the categoriza-
tions of these sequence observations. Specifically, if the
ith sequence observation is generated by isoform Ik, then
zi,k ¼ 1; otherwise, zi,k ¼ 0.
The probabilities (pk, k ¼ 1, . . . , K) can be estimated by
isoform proportions. Specifically, we count the number of
Figure 1. Splice graph of a three-exon alternatively spliced gene. (a) Gene
structure for a three-exon gene. The second exon is a cassette exon. (b) The
splice graph representation of the gene structure. The exon skipping event is
represented by a directed edge from node 1 to node 3.
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sequence observations that are generated by isoform k, i.e.
nk ¼
PN
i¼1 zi‚ k, then the estimated probability p^k ¼ nk/N.
The complication is that most sequence observations are
not of full-length, so that they are consistent with more
than one isoform. Therefore, the indicator matrix Z is not
fully observed. What is observed is another indicator matrix
Y ¼ (yi,k)i¼1, . . . , N;k¼1, . . . , K, where yi,k ¼ 1 if the ith sequence
observation is consistent with isoform Ik, and yi,k ¼ 0 other-
wise. Unlike matrix Z, which has one and only one 1 in each
row, the matrix Y has one or more 1’s in each row. If yi,k ¼ 0,
then zi,k must be 0, but if yi,k ¼ 1, then zi,k may or may not be
1. We call Y the uncommitted categorization, and Z the
underlying committed categorization.
We denote q ¼ (p1, . . . , pK). The log likelihood function of
the multinomial model with uncommitted categorization is
lðq j YÞ ¼
XN
i¼1
log
XK
k¼1
yi‚ kpk
 !
:
The maximum likelihood estimates (MLE) of q,
q^ ¼ arg maxq lðq j YÞ, cannot be obtained in closed-form.
EM: soft categorization and fractional counts. The EM
algorithm (35) can be used to compute the maximum likeli-
hood estimates (MLE) of the category probabilities q ¼ (pk,
k ¼ 1, . . . , K) from the observed data Y. The EM algorithm
is an iterative algorithm. In describing the algorithm, we
add subscript q(t) to the relevant quantities. For instance,
q(t) is the parameter value computed after t th iteration. The
algorithm starts from an initial guess qð0Þ ¼ ðpð0Þk ‚
k ¼ 1‚ . . . ‚KÞ. For instance, pð0Þk ¼ 1/K: Each iteration is a
mapping from q(t) to q(t+1), which is accomplished via the fol-
lowing two steps:
E-step:
z
ðtþ1Þ
i‚ k ¼ E½zi‚ k j Yi‚qðtÞ ¼ Prðzi‚ k ¼ 1 j Yi‚qðtÞÞ
¼ yi‚ kp
ðtÞ
kPK
k¼1 yi‚ kp
ðtÞ
k
‚8i‚k:
M-step: Let n
ðtþ1Þ
k ¼
XN
i¼1
z
ðtþ1Þ
i‚ k ‚ 8k,
p
ðtþ1Þ
k ¼
n
ðtþ1Þ
k
N
‚ 8k:
Intuitively, the E-step splits the ith sequence observation into
different isoforms. Each isoform k with yi,k ¼ 1 gets a fraction
of Oi in proportion to p
ðtÞ
k , and this fraction is z
ðtþ1Þ
i‚ k . We call
this soft categorization. The M-step updates the probability of
each isoform by counting the sequence observations that are
categorized into this isoform. Because of soft categorization,
we have to sum up the fractional indicators as if they were
0/1 indicators.
We can run this algorithm until j qðtþ1Þ 
 qðtÞ j ¼ PKk¼1j pðtþ1Þk 
 pðtÞk j < e, where e is a pre-specified stopping cri-
terion. Throughout this manuscript, we used an e of 10
6.
The algorithm is justified in Appendix 1 of the online sup-
plements. The standard errors of the parameter estimates can
be obtained after EM converges. See Appendix 2 of the
online supplements.
Simulation study
We performed a simulation study to examine the robustness
of our EM algorithm against sampling biases in the input
data. EST generation is subject to two major sources of
variation: (i) isoform sampling based on isoform abundance
and (ii) random fragmentation of isoforms. These variations
translate into the variation in the MLE estimates of the
probabilities. We simulated a gene with 10 exons. The
terminal exons were 250 bp in length. All the internal
exons were 150 bp. Exon 2 and 9 were alternatively spliced
cassette exons. Four isoforms can be generated from this
gene: the isoform with all exons, the isoform without
exon 2, the isoform without exon 9, and the isoform without
exon 2 and 9 (see Table 1).
We set certain fixed probabilities for these isoforms
(see Table 1). We generated a simulated expressed sequence
using the following three-step procedure: (i) randomly sam-
ple the four isoforms, to generate a full-length mRNA,
(ii) randomly sample the empirical distribution of the length
of ESTs (taken from human UniGene data, see Supplement-
ary Data), to decide the length of the simulated expressed
sequence and (iii) randomly truncate the simulated mRNA
according to the length obtained from the previous step, to
make the simulated expressed sequence. If the length was
longer than the mRNA, the whole mRNA was the simulated
expressed sequence.
After gathering N (N ¼ 10, 25, 50, 100 and 250) simulated
expressed sequences, we ran the EM algorithm to obtain the
estimates of probabilities. The deviation of the estimated
probabilities from the truth was measured by the total vari-
ation distance, which is 1
2
P4
i¼1 j p^i 
 pi j. For each N, we
repeated the process 100 times and inspected the distributions
of the total variation distance.
Probabilistic isoform reconstruction using
human expressed sequence data
For a human gene, we aligned all of its mRNA and EST
sequences to its genomic sequence using POA (45), and cal-
culated the exons and splicing events from the multiple
sequence alignment (15), using June 2003 download of Uni-
Gene data and human genome sequences. We constructed the
splice graph based on observed splicing events among its
exons in the expressed sequence data. Details of the splice
graph construction were described in Xing et al. (15). We
enumerated all possible traversals across the splice graph as
the total set of putative isoforms, using a BFS algorithm.
We used the EM algorithm described above to estimate the
probability of each isoform.
Table 1. The simulation study to test the robustness of the EM algorithm
Isoform Probability
in set a
Probability
in set b
Probability
in set c
Probability
in set d
1-2-3-4-5-6-7-8-9-10 0.25 0.5 0 0.95
1-3-4-5-6-7-8-9-10 0.25 0 0.5 0
1-2-3-4-5-6-7-8-10 0.25 0 0.5 0
1-3-4-5-6-7-8-10 0.25 0.5 0 0.05
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Figure 2. Probabilistic isoform reconstruction for a simulated gene. Left panel: sequence observations; right panel: results of probabilistic isoform reconstruction.
The upper graph indicates the overall log likelihood; the lower graph shows the estimated probabilities for individual isoforms until convergence. A–D represents
different situations of sequence observations.
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RESULTS
Probabilistic isoform reconstruction for a
simulated gene
To test and illustrate the behavior of the EM algorithm, we
designed a simulated gene with 5 exons. Exon 2 and
4 were cassette exons that could be skipped entirely. An
exhaustive traversal of this splice graph produced four iso-
forms for this gene: the one that contained all 5 exons
(FL), the one that lacked exon 2 (D
2), the one that lacked
exon 4 (D
4) and the one that lacked both exon 2 and 4
(D
2, 4). Of course, the result of our probabilistic isoform
reconstruction should be dependent on the actual sequence
observations for this gene.
We designed four different sets of sequence observations,
and ran the EM algorithm on each of them to infer isoform
probabilities. Each set contained 20 sequences, and represen-
ted distinct situations of sequence observations. Details of
these dataset are illustrated in Figure 2 (left panels).
In sequence set 1, each sequence indicated the inclusion or
skipping of one cassette exon (exon 2 or exon 4). No
sequence covered both alternatively spliced regions. Five
sequences contained exon 1 and 3, indicating the skipping
of exon 2; five sequences contained exon 1, 2 and 3, indicat-
ing the inclusion of exon 2. These ten sequences gave no
information about the inclusion or skipping of exon 4. Simil-
arly, five sequences indicated the inclusion and another five
sequences indicated the skipping of exon 4, but carried no
information on the status of exon 2. In summary, this
sequence dataset represented a situation where all the input
sequences were highly fragmented. There was no indication
on how cassette exon 2 and 4 were combined in the final tran-
scripts. Our EM algorithm converged at equal probabilities
for all possible isoforms (see Figure 2A, right panel).
Sequence set 2 represented a completely opposite situation.
Every sequence in set 2 was a full-length sequence. Twelve
sequences contained all 5 exons, and eight sequences
contained only exon 1, 3 and 5. Obviously, although we
could produce four different traversals across this splice
graph, only two traversals were observed in our input data
and were necessary to explain all the 20 sequences. In fact,
the skipping events of exon 2 and exon 4 were always
coupled in the input data. Initiating from equal probabilities
(0.25) for all isoforms, our EM algorithm converged at
0.6 for the FL and 0.4 for the D
2,4 isoform, and 0 for the
D
2 and D
4 isoform (see Figure 2B). The result of our
EM algorithm was consistent with the proposed strategy of
producing a minimal set of isoforms to explain all
the sequence observations (15,21,22).
Sequence set 3 contained both full-length sequences and
sequence fragments (see Figure 2C, left panel). It was easy
to notice that six sequence fragments (which contained
exon 3, 4 and 5) were consistent with both FL and
D
2 isoforms. During the iterations, the categorization of
these six sequences to the FL and D
2 isoform was gradually
assigned to the FL isoform, due to additional sequence evid-
ence (nine sequences) that only supported the FL isoform.
The algorithm converged at 0.75 for the FL and 0 for the
D
2 isoform. A similar situation occurred during the probab-
ility estimation for the other two isoforms: D
2,4 received a
probability of 0.25 while D
4 received a probability of 0 (see
Figure 2C, right panel).
In sequence set 4, all four isoforms were observed in the
input data. Our EM algorithm converged at non-zero probab-
ilities for all isoforms (see Figure 2D).
The results of our probabilistic isoform reconstruction on
this simulated gene indicate that our EM algorithm can
correctly handle various situations of fragmentation and
coupling in the sequence data. It produces the most likely
probability estimate for each isoform by considering all
the sequence observations simultaneously. Unlike our pre-
vious method (15), this probabilistic reconstruction is
completely independent of the order of input sequence
observations.
D
Figure 2. Continued
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Simulation study to test the robustness of the
EM algorithm
Sampling biases in the input data can affect the maximum
likelihood estimates of the isoform probabilities. In particu-
lar, when the number of sequence observations for a gene
is relatively small, the MLE might have considerable devi-
ations from the true isoform probabilities. To assess the
impact of sampling biases, we performed a simulation
study on a simple gene model with 10 exons. We used four
sets of probability distributions of isoforms (see Table 1),
and then simulated the process of random EST generation
(see Materials and Methods). For each probability distribu-
tion we randomly generated 10, 25, 50, 100 and 250
sequences (see Materials and Methods).
We compared our MLE estimates to the true probabilities
to calculate the total variation distance (see the definition in
Materials and Methods). When the total number of sequence
observations was only 10, there was a considerable difference
between the estimated isoform probabilities and the true
probabilities. By contrast, with 250 sequence observations,
these two sets of probabilities were fairly close (see
Figure 3A). An additional simulation that randomly initiated
the true probability distribution of all isoforms produced a
similar result (see Figure 3B). As expected, our simulation
study indicates that the accuracy of our estimates is depend-
ent on the number of sequence observations for a gene.
Isoform reconstruction using expressed
sequence data for HLA-DMB and TPM1
Figure 4A shows the gene structure for a well-studied gene
HLA-DMB. HLA-DMB plays an important role in antigen
presentation and the activation of the humoral immune
response, by facilitating the loading of class II MHC
molecules with exogenous peptide antigens (46–48). This
process occurs in early lysosomal compartments. HLA-DMB
has 6 exons. Exon 4 encodes a hydrophobic transmembrane
(TM) domain, and exon 5 encodes a lysosomal targeting
(LT) signal. Our EST-genome alignment revealed alternative
splice forms that skipped exon 4 or exon 5 of HLA-DMB, or
both. Therefore in addition to the FL form of HLA-DMB,
expressed sequence data indicate three additional isoforms
that lack the TM domain (D-TM), or the LT signal (D-LT),
or both (D-TM and LT). By excluding likely EST artifacts
from unspliced genomic DNA (1), we used 97 cDNA/EST
sequences as the input data for our probabilistic isoform
reconstruction. Our calculation shows that the FL HLA-
DMB is the predominant isoform for this gene, with an estim-
ated probability of 0.732. The three shorter HLA-DMB iso-
forms are present at a much lower level (see Figure 4C).
The probability estimates of these HLA-DMB isoforms
agree well with our RT–PCR analysis of HLA-DMB isoforms
(Figure 4D; see Appendix 3 of the online supplements for
details on RT–PCR analyses and sequencing of HLA-DMB).
We also reconstructed isoforms for Tropomyosin 1
(TPM1). TPM1 has multiple regions with complicated pat-
terns of alternative splicing. Even after we excluded likely
EST artifacts, the remaining sequence observations still
gave rise to a splice graph with 16 possible traversals. Previ-
ous studies of TPM1 alternative splicing revealed two major
alternative splicing events: the mutually exclusive usage of
exon 6a and 6b; the alternative use of exon 9/10 or exon
11 as the 30 terminal exons (see Figure 5A). There is evidence
in the expressed sequence data that alternative splicing of
these two regions is not independent (see Figure 5B). In
fact, quantitative PCR analyses of TPM1 alternative splicing
showed that the inclusion of exon 6b together with exon 9/10
was the predominant isoform in muscle (49). On the other
hand, the inclusion of exon 6a and exon 11 was predominant
in non-muscle tissues (49). Although such coupling infor-
mation was present in the input sequence observations, our
previous isoform generation method failed to capture such a
signal for coupled alternative splicing events (15), demon-
strating the limitation of dynamic programming in recogniz-
ing coupled edges in the splice graph. By contrast, our EM
algorithm converged at five isoforms with an inferred
probability of at least 0.05. The two isoforms that received
the highest probability estimates corresponded to the muscle-
specific and non-muscle isoforms of TPM1 (see Figure 5C).
This analysis demonstrates that our EM algorithm provides
a global, probabilistic solution that can deal with coupling
events in the splice graph.
Isoform reconstruction for genes on human
chromosome 22
To assess the computational feasibility of our algorithm, we
performed isoform reconstruction for 186 alternatively
spliced genes from human chromosome 22. We recorded
the computation time on a PC (AMD Athlon 1500+ with
320MB of RAM) for each gene. The result is plotted in
Figure 6. The average CPU time is 6.7 seconds. The maximal
CPU time is 298.1 seconds for Hs.26593 (HDAC10), which
has 768 possible traversals across its splice graph. This
analysis demonstrates that our algorithm is computationally
feasible.
One important and difficult aspect of isoform reconstruc-
tion is to assess the confidence in different traversals of the
splice graph, by integrating full-length sequences and
sequence fragments. A widely used approach in non-
probabilistic isoform reconstruction method is to evaluate
isoforms based on numbers of consistent sequence evidence.
For each of the 186 UniGene clusters on chromosome 22,
we scored its putative isoforms using (i) probability estimates
from our EM algorithm; (ii) numbers of consistent sequence
evidence. We classified all putative isoforms into two
categories: those with mRNA evidence, and those with
only EST evidence. The first category was treated as
goldstandard high-confidence isoforms, since the presence
of mRNA evidence was widely used as a criterion for real
isoforms, as opposed to rare spliceosomal errors or EST
artifacts (1). For UniGene clusters on chromosome 22 with
both mRNAs and ESTs, we summed the scores for both
categories of putative isoforms separately and calculated
their ratio. Using probability estimates as the scores, the
overall ratio (isoforms with mRNA evidence versus isoforms
with only EST evidence) is 4.5. By contrast, scoring by
numbers of consistent sequence evidence yielded an
overall ratio of 1.1. This analysis indicates that a higher
probability out of our EM algorithm is correlated with a
higher confidence in the putative isoforms. Isoform evalu-
ation by EM has a more significant tendency of favoring
Nucleic Acids Research, 2006, Vol. 34, No. 10 3155
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Figure 3. Simulation study to test the robustness of the EM algorithm. X-axis: the total number of sequence observations being simulated; Y-axis: the total
variation distance between the true probabilities and the estimated probabilities (see Materials and Methods). (A) Simulation studies using fixed probabilities of
four isoforms. The probabilities are listed in Table 1. (B) A simulation study using randomized probabilities of four isoforms.
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high-confidence isoforms, compared to the non-probabilistic
method. In addition, EM algorithm does a much better job
in distinguishing high-scoring isoforms from low-scoring iso-
forms (data not shown).
DISCUSSION
Our study is an extension to a large body of previous work
which reconstruct full-length isoforms from the splice graph
(15,19–26). An essential question in every isoform recon-
struction method is how to integrate evidence from full-
length sequences and sequence fragments. This question is
complicated by the combinatorial nature of alternative
splicing, i.e. a sequence fragment can be consistent evidence
for a large number of isoforms. Some previous studies
enumerate all possible isoforms (23,24). Several others use
certain rules to produce a minimal set of isoforms sufficient
to explain all the input data (15,20–22). The resulting min-
imal set of isoforms can be input-order dependent (15,18).
There is a genuine need for a global consideration of all
the observational data simultaneously, and a probabilistic
approach to measure evidence for every possible traversal
across the splice graph. In this manuscript, we introduce a
probabilistic formulation of the isoform reconstruction
problem, and describe an EM algorithm for its maximum
likelihood solution. Through the analyses of simulated data
and sequence data of real human genes, we demonstrate
that our algorithm provide a robust, probabilistic solution
for various situations of fragmentation and coupling in the
input data.
Our probabilistic framework provides the basis for several
areas of extensions. One extension is to account for errors or
redundancies in the sequence observations. For example, EST
data contain various types of artifacts. Sorek and colleagues
(50,51) proposed a method to detect EST libraries with
high levels of artifacts. It has also been suggested that due
to issues related to the normalization of cDNA libraries
(52), multiple ESTs from a single library should be regarded
as weaker evidence for an alternative splice form than the
same number of ESTs from different libraries. We can use
an additional weighting parameter to reflect our confidence
about an individual EST sequence. This weighting parameter
can be easily incorporated in the EM algorithm for
maximum likelihood estimation. Specifically, we can write
the log likelihood as the weighted sum of the individual log
terms, and this leads to an EM algorithm where the sum of
zi,k becomes the weight sum of zi,k. Of course, we can also
be more formal by adding an extra layer of randomization
in the model to reflect the uncertainty in the sequence obser-
vations, and then develop the EM algorithm for maximum
likelihood estimation.
A second extension is to detect full-length isoforms that
are specifically enriched in certain conditions (e.g. tissues,
A B
C
D
Figure 4. Probabilistic isoform reconstruction for HLA-DMB. (A) Gene structure and alternative splicing of HLA-DMB. Exon 4 encodes the TM domain. Exon
5 encodes the LT signal. (B) Four putative isoforms of HLA-DMB. (C) Probabilistic isoform reconstruction of HLA-DMB. The upper graph indicates the overall
log likelihood; the lower graph shows the estimated probabilities for individual isoforms until convergence. The FL form has the highest estimated probability,
followed by D-LT, D-TM and D-TM,LT. (D) RT–PCR analysis of HLA-DMB isoforms in pooled human tissues (see Appendix 3 of the online supplements for
details of the experiment). Left lane: marker; Right lane: HLA-DMB.
Nucleic Acids Research, 2006, Vol. 34, No. 10 3157
developmental states, diseases) by considering the origin of
sequence observations. Several studies used expressed
sequences to detect tissue-specific and cancer-specific exons
(8,52–54). However, information of specificity in sequence
fragments cannot be directly translated into knowledge
about full-length tissue-specific and cancer-specific isoforms.
In our current probabilistic framework, the EM algorithm can
run separately on different sets of sequence observations for a
given gene (e.g. one set from cancerous libraries and another
set from normal libraries). The likelihood ratio test (LRT)
can be used to assess whether the abundance of a particular
isoform varies significantly across different sets of sequence
observations.
One of the most exciting future developments is to
incorporate splicing microarray data. Recently, microarray
technology has been developed for high-throughput analyses
of alternative splicing (2,16). By designing probes targeting
specific exons or exon–exon junctions, microarray allows a
rapid quantitative analysis of alternative splicing of thousands
of exons on a single array. However, the signal from micro-
array experiments is even more fragmented compared to
expressed sequences. There will be a growing need for an
isoform reconstruction method that integrates sequence data
(e.g. expressed sequences) and microarray probe signals
(55). We will describe our splice graph-based analysis of
splicing microarray data in a separate manuscript.
A
C
B
Figure 5. Probabilistic isoform reconstruction for TPM1. (A) The gene structure of TPM1 from exon 4 to exon 11. (B) EST evidence indicates coupled
alternative splicing events in TPM1. (C) Probabilistic isoform reconstruction of TPM1. The upper graph indicates the overall log likelihood; the lower graph
shows the estimated probabilities for individual isoforms until convergence. Only isoforms with >0.05 probability are shown in the graph.
Figure 6. CPU time of probabilistic isoform reconstruction for 186 genes on
human chromosome 22. X-axis: numbers of putative isoforms. Y-axis: CPU
time on a PC (AMD Athlon 1500+ with 320MB of RAM).
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